Kauffman FastTrac® TechVentureTM Program supported by Georgia CTSA's Innovation Catalyst Program
Emory University’s Office of Technology Transfer and Georgia CTSA’s Innovation Catalyst program are providing tools to support researchers in business. The Kauffman FastTrac® TechVentureTM program is a proven entrepreneur training course designed to help technology/science-based faculty entrepreneurs grow a great idea into a successful business. Kauffman recognizes that the innovation landscape is changing and the most complicated tech transfer deals are startups. Faculty founders play a critical role in startups and the solution is to provide a course to advance entrepreneurship.
The program provides faculty with tools necessary to start or run a virtual or early-stage company. The Emory Source Syllabus for the Kauffman FastTrac® TechVentureTM program includes concept analysis from exploring entrepreneurship to testing your business concept. The course also includes business planning from entering and capturing the market, protecting the business and your intellectual property to managing cash and operating your business. Introductory Video
The Georgia Clinical & Translational Science Alliance (Georgia CTSA) provides resources for start-up research projects through the Innovation Catalyst program. Innovation Catalyst offers funding for start-up research projects, better access to analytical tools, and education and training to clinical and translational investigators. Georgia CTSA provides the infrastructure and programmatic foundation to rapidly identify and invest in promising technologies and enhance collaborative opportunities among translational investigators and industry partners. A goal of Georgia CTSA is to catalyze development, validation, and commercialization of translational technologies.
The Georgia CTSA partners with Emory University, Morehouse School of Medicine, Georgia Tech, and the University of Georgia to concentrate basic, translational, and clinical research investigators, community clinicians, professional societies, and industry collaborators in dynamic clinical and translational research projects. Georgia CTSA is one of nearly 60 in a national consortium striving to improve the way biomedical research is conducted across the country. The consortium, funded through the National Center for Advancing Translational Sciences (NCATS) and the National Institutes of Health’s Clinical and Translational Science Awards, shares a common vision to translate laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train the next generation of clinical investigators.